Edaravone attenuates hydroxyl radical stress and augmented angiotensin II response in diabetic rats

Pharmacological Research

Volumn 54, Issue 1, 2006, Pages 6-10

  Saini, Anuj Kumar ^a,c   Patel, Rashwin J ^b,c   Sharma, Shyam S ^c   H S , Arun Kumar ^c,d  

^a Torrent Research Centre   (India)

^b GANPAT UNIVERSITY   (India)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin; Diabetes; Edaravone; Hydroxyl radical; Streptozotocin

Indexed keywords

ANGIOTENSIN II; CATALASE; NORPHENAZONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EVALUATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; THORACIC AORTA;

ANGIOTENSIN II; ANIMALS; ANTIPYRINE; AORTA, THORACIC; BLOOD PRESSURE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TERT-BUTYLHYDROPEROXIDE; VASOCONSTRICTION;

EID: 33745059705     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.02.003     Document Type: Article

References (40)

1. 2 receptor mediated relaxation in diabetic rat thoracic aorta. J Hypertens 22 (2004) 2143-2152
2. 1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats. Cardiovasc Res 65 (2005) 374-386
3. Arun K.H.S., and Ramarao P. Saga of renin-angiotensin system and calcium channels in hypertensive diabetics: does it have a therapeutic edge?. Cardiovasc Drug Rev 23 (2005) 99-114
4. Saini A.K., Arun K.H.S., Kaul C.L., and Sharma S.S. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine. Pharmacol Res 50 (2004) 593-599
5. 2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy. Neurol Res 27 (2005) 60-66
6. Son S.M., Whalin M.K., Harrison D.G., Taylor W.R., and Griendling K.K. Oxidative stress and diabetic vascular complications. Curr Diab Rep 4 (2004) 247-252
7. Srikumar B., Shailesh S., Ramarao P., and Kaul C.L. Selective attenuation of enhanced angiotensin II mediated responses in the streptozotocin diabetic rat thoracic aorta by tempol. In: Pierce G., Nagano P., and Dhalla N. (Eds). Atherosclerosis, hypertension and diabetes (2003), Kluwer Academic Publishers, Boston 327-337
8. 1 receptors in control but not diabetic rat thoracic aorta. Pharmacol Res 50 (2004) 561-568
9. 2 angiotensin II receptors: key features. Drugs 62 (2002) 1-10
10. Spitaler M.M., and Graier W.F. Vascular targets of redox signalling in diabetes mellitus. Diabetologia 45 (2002) 476-494
11. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
12. Touyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 37 (2004) 1263-1273
13. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., and Griendling K.K. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271 (1996) 23317-23321
14. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Brasen J.H., Skatchkov M., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99 (1999) 2027-2033
15. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32 (1998) 488-495
16. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
17. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 29-38
18. Pieper G.M., Langenstroer P., and Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 34 (1997) 145-156
19. Shastri S., Gopalakrishnan V., Ramarao P., and Di Wang H. Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats. J Hypertens 20 (2002) 1381-1391
20. Otani H., Togashi H., Jesmin S., Sakuma I., Yamaguchi T., Matsumoto M., et al. Temporal effects of edaravone, a free radical scavenger, on transient ischemia-induced neuronal dysfunction in the rat hippocampus. Eur J Pharmacol 512 (2005) 129-137
21. Toyoda K., Fujii K., Kamouchi M., Nakane H., Arihiro S., Okada Y., et al. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci 221 (2004) 11-17
22. Grover A.K., Hui J., and Samson S.E. Catalase activity in coronary artery endothelium protects smooth muscle against peroxide damage. Eur J Pharmacol 387 (2000) 87-91
23. Beltowski J., Wojcicka G., Gorny D., and Marciniak A. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 51 (2000) 883-896
24. Jagadeesh G. Angiotensin II receptors - antagonists, molecular biology and signal transduction. Ind J Exp Biol 36 (1998) 1171-1194
25. Touyz R.M., and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35 (2002) 1001-1015
26. Da Ros R., Assaloni R., and Ceriello A. Antioxidant therapy in diabetic complications: what is new?. Curr Vasc Pharmacol 2 (2004) 335-341
27. Ha H., and Lee H.B. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int Suppl 77 (2000) S19-S25
28. 2 in aorta isolated from chronically streptozotocin-diabetic rats: effects of antioxidant enzymes and enzymes inhibitors. Free Radic Biol Med 27 (1999) 16-27
29. Peiro C., Lafuente N., Matesanz N., Cercas E., Llergo J.L., Vallejo S., et al. High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br J Pharmacol 133 (2001) 967-974
30. Shastri S., Rodert McNeil J., Thomas W.W., Ramarao P., Kaul C.L., and Gopalakrishnan V. Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin I in SHR. Am J Physiol Heart Circ Physiol 281 (2001) H342-H349
31. Torrecillas G., Boyano-Adanez M.C., Medina J., Parra T., Griera M., Lopez-Ongil S., et al. The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 59 (2001) 104-112
32. Zobali F., Besler T., Ari N., and Karasu C. Hydrogen peroxide-induced inhibition of vasomotor activity: evaluation of single and combined treatments with vitamin A and insulin in streptozotocin-diabetic rats. Int J Exp Diabetes Res 3 (2002) 119-130
33. 2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 28 (2000) 91-101
34. Ulker S., McMaster D., McKeown P.P., and Bayraktutan U. Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res 59 (2003) 488-500
35. Bergendi L., Benes L., Durackova Z., and Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci 65 (1999) 1865-1874
36. Abe S., Kirima K., Tsuchiya K., Okamoto M., Hasegawa T., Houchi H., et al. The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radical. Chem Pharm Bull (Tokyo) 52 (2004) 186-191
37. Yagi H., Horinaka S., and Matsuoka H. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat. J Cardiovasc Pharmacol 46 (2005) 46-51
38. Yoshida H., Sasaki K., Namiki Y., Sato N., and Tada N. Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase. Atherosclerosis 179 (2005) 97-102
39. Mishina M., Komaba Y., Kobayashi S., Tanaka N., Kominami S., Fukuchi T., et al. Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction. Neurol Med Chir (Tokyo) 45 (2005) 344-348
40. Hayashi T., Mori T., Sohmiya K., Okada Y., Inamoto S., Okuda N., et al. Efficacy of edaravone, a free radical scavenger, on left ventricular function and structure in diabetes mellitus. J Cardiovasc Pharmacol 41 (2003) 923-929